Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Greater Light Exposure Before Bed Linked to Increased Risk for GDM
WEDNESDAY, March 29, 2023 -- Greater light exposure in the three hours before bed is associated with an increased risk for gestational diabetes mellitus (GDM)...
Fatal Drug Overdose Down With OUD-Related Telehealth Services
WEDNESDAY, March 29, 2023 -- Receipt of opioid use disorder (OUD)-related telehealth services during the COVID-19 pandemic was associated with a reduced risk...
FDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses
WEDNESDAY, March 29, 2023 -- The U.S. Food and Drug Administration on Wednesday approved the over-the-counter (OTC) use of naloxone (Narcan). "Today's...
Lawmakers Want to Tighten Access to Veterinary Drug Xylazine
WEDNESDAY, March 29, 2023 -- Congressional leaders introduced a bill on Tuesday that would further restrict access to the veterinary drug xylazine, which is...
WHO: Healthy Children, Teens May Not Need More COVID-19 Shots
WEDNESDAY, March 29, 2023 -- New advice from the World Health Organization says healthy children and teens may not need additional COVID-19 shots, though they...
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ Narcan Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
GAITHERSBURG, Md., March 29, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA)...
Long-Term Waterborne-Ingested Nitrate Linked to Prostate Cancer Risk
WEDNESDAY, March 29, 2023 -- Long-term waterborne-ingested nitrate is associated with an increased risk for prostate cancer, especially aggressive tumors...
WHO Experts Say Healthy Kids, Teens May Not Need More COVID Shots
WEDNESDAY, March 29, 2023 -- New advice from the World Health Organization (WHO) says healthy children and teens may not need additional COVID-19 shots, though...
Nerve 'Pulse' Therapy May Help Ease Sciatica
WEDNESDAY, March 29, 2023 -- People suffering from sciatica gain lasting relief from a procedure that uses a fine needle to heat nerve roots near the spine, a...
FDA Approves First Over-the-Counter Naloxone Nasal Spray for Opioid Overdoses
WEDNESDAY, March 29, 2023 -- The U.S. Food and Drug Administration on Wednesday approved the over-the-counter use of a nasal spray that can reverse an opioid...
Could COVID in Pregnancy Raise Odds for Obese Kids?
WEDNESDAY, March 29, 2023 -- The consequences of COVID-19 during pregnancy are still unfolding, but a new study delivers sobering news: Prenatal exposure to...
FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)
LEIDEN, The Netherlands, March 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces...
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s...
FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis
SAN DIEGO & PARSIPPANY, N.J.--(BUSINESS WIRE)-- March 22, 2023 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced...
FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)
WILMINGTON, Del.--(BUSINESS WIRE)--Mar. 22, 2023-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz...
FDA Approves First-in-class Evkeeza (evinacumab-dgnb) for Young Children with Ultra-Rare Form of High Cholesterol
TARRYTOWN, N.Y., March 22, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA)...
AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application
NORTH CHICAGO, Ill., March 22, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and...
Ionis Announces FDA Acceptance of New Drug Application for Eplontersen for the Treatment of Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (ATTRv-PN)
35-week data included in the filing demonstrated a statistically significant and clinically meaningful change from baseline for co-primary and secondary...
Avadel Pharmaceuticals Requests Final FDA Approval for Lumryz (sodium oxybate) Extended-Release Oral Suspension
DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to...
FDA Accepts for Priority Review ADX-2191 New Drug Application for the Treatment of Primary Vitreoretinal Lymphoma
LEXINGTON, Mass.--(BUSINESS WIRE) March 2, 2023 --Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug...
New data presented at AD/PD 2023 show IONIS-MAPT Rx (BIIB080) substantially reduced tau protein in patients with early-stage Alzheimer's disease
CARLSBAD, Calif., March 29, 2023. Ionis Pharmaceuticals, Inc. today reported that its partner Biogen presented new Phase 1b clinical data showing that...
Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
TARRYTOWN, N.Y., and SOUTH SAN FRANCISCO, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sonoma Biotherapeutics...
NIH Researchers Discover New Autoinflammatory Disease, Suggest Target for Potential Treatments
March 28, 2023 -- Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in...
Trial Results for Ovarian Cancer will lead to new Standard of Care
MIAMI BEACH, Fla., March 28, 2023. Mount Sinai Medical Center (MSMC) is pleased to announce the results of a clinical trial led by Brian Slomovitz, MD...
Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease
NEW ORLEANS and CAMBRIDGE, England, March 27, 2023. Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.